Ultime notizie per Howmet Aerospace (NYSE:HWM) Azioni

HOWMET AEROSPACE INC

Howmet Aerospace

Howmet Aerospace Inc produces products that are majorly used in aerospace, commercial transportation, and industrial and other markets. The company seeks to provide its customers with solutions by offering differentiated products such as airfoils with cooling and coatings for extreme temperature applications, specially designed fasteners for lightweight composite airframe construction, reduced assembly costs, lightning strike protection, and lightweight aluminum commercial wheels. It has four reportable segments namely, Engine Products, Fastening Systems, Engineered Structures, and Forged Wheels.

Shibuya,,Tokyo,,Japan,-,March,5,2022:,Exterior,Of,The

Long Ideas

Tech

Trading Ideas

PLTR

UBER

VRSN

Le azioni dell&#39;S&amp;P 500 che stanno registrando le migliori performance dell&#39;anno. Quali sono le società in forte crescita?

I migliori performer dell&#39;S&amp;P 500: ecco le azioni che stanno volando alto

Howmet Aerospace Inc

HOWA MACHINERY LTD by HOWA MACHINERY LTD.

Howmet Aerospace Inc. $3.75 Preferred Stock

<a href="https://www.nytimes.com/2025/06/11/us/politics/republicans-trump-populist-tax-cuts.html" title="https://www.nytimes.com/2025/06/11/us/politics/republicans-trump-populist-tax-cuts.html">https://www.nytimes.com/2025/06/11/us/politics/republicans-trump-populist-tax-cuts.html</a>

Macro Economic Events

News

Politics

Economics

General

'Senate Republicans Want to Trim Some of Trump's Populist Tax Cuts' - NY Times

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) with a Buy and maintains $12 price target.

Price Target

Reiteration

Analyst Ratings

FEMY

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $12 Price Target

PZZA

Papa John's International Shares Resume Trade

Benchmark analyst Cody Acree reiterates Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) with a Buy and maintains $6 price target.

INDI

Benchmark Reiterates Buy on Indie Semiconductor, Maintains $6 Price Target

WIIM

GROY

Gold Royalty shares are trading higher after Canaccord Genuity initiated a Buy rating on the stock and announced a $3 price target.

Papa John's shares are trading higher following a report indicating Apollo and Irth Capital are looking to take the company private.

<a href="https://www.stripes.com/theaters/middle_east/2025-06-11/us-embassy-baghdad-nonessential-staff-leave-18089220.html" title="https://www.stripes.com/theaters/middle_east/2025-06-11/us-embassy-baghdad-nonessential-staff-leave-18089220.html">https://www.stripes.com/theaters/middle_east/2025-06-11/us-embassy-baghdad-nonessential-staff-leave-18089220.html</a>

Global

'U.S. Prepares To Order Departure Of All Nonessential Staff From Baghdad Embassy, Officials Say' - Stars And Stripes

INUV

Inuvo shares are trading lower. The company effected a 1-for-10 reverse split.

Needham analyst Quinn Bolton reiterates IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) with a Buy and maintains $50 price target.

IONQ

Needham Reiterates Buy on IonQ, Maintains $50 Price Target

CGNT

Cognyte Software shares are trading lower. The company reported Q1 financial results.

The U.S. Food and Drug Administration (FDA) on Wednesday approved Nuvation Bio Inc.&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NASDAQ">NUVB</a>) Ibtrozi (taletrectinib) for adult patients with locally advanced or metastatic ROS1-positive (ROS1+) <a href="https://www.benzinga.com/general/health-care">non-small cell lung cancer (NSCLC)</a>.
The FDA approval of Ibtrozi is supported by one of the largest global clinical trial programs in ROS1+ NSCLC to date, with over 300 patients enrolled in the pivotal TRUST-I and TRUST-II studies.
In the TRUST-I trial, Ibtrozi achieved a confirmed overall response rate (cORR) of 90% in TKI-naïve (untreated) patients.
Also Read: <a href="https://www.benzinga.com/general/biotech/24/08/40168834/small-cap-cancer-focused-nuvation-bio-pulls-plug-on-early-stage-program-after-considering-phase-1" target="_blank" rel="noreferrer noopener">Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data</a>
TRUST-II trial showed a cORR of 85% in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45890099/u-s-food-and-drug-administration-approves-nuvation-bios-ibtrozi-taletrectinib-a-next-generation-or" rel="noreferrer noopener">TKI-naïve patients</a>.
The median duration of response (DOR) was not yet reached for either trial, based on a cutoff date nearly five months later than that of the pooled TRUST-I and TRUST-II analysis published in April in the&nbsp;Journal of Clinical Oncology.
For TRUST-I, with a median follow-up for responses of 40 months, the longest DOR was observed at 46.9 months and ongoing.
For TRUST-II, with a median follow-up for responses of 19 months, the longest DOR was observed at 30.4 months and ongoing as of October 2024.
Given the single-arm nature of the TRUST clinical studies, median progression-free survival (PFS) is not provided in the label.
Across the pivotal studies, consistent results were also observed among patients previously treated with a ROS1 TKI (TKI-pretreated).
In TRUST-I, treatment with Ibtrozi achieved a cORR of 52% and a median DOR of 13.2 months for TKI-pretreated patients, with a median follow-up for responses of 33 months.
In TRUST-II, treatment with Ibtrozi achieved a cORR of 62%. As of October 2024, the median DOR was 19.4 months in these patients, with a median follow-up for responses of 19 months.
An intracranial response was achieved in 73% of TKI-naive patients (11/15) and 63% of TKI-pretreated patients (15/24).
Price Action: NUVB stock is trading lower by 16.8% to $2.105 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/biotech/25/05/45450474/immutep-reports-61-response-rate-in-lung-cancer-trial-with-keytruda-based-triple-combo" target="_blank" rel="noreferrer noopener">Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo</a></li>
</ul>
Photo by Aunt Spray via Shutterstock

Biotech

Health Care

Movers

NUVB

Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval

MIND

MIND Technology shares are trading lower after the company reported worse-than-expected Q1 financial results.

Fartcoin (CRYPTO: FARTCOIN) is turning heads after a <a href="https://www.benzinga.com/money/fartcoin-price-prediction#:~:text=Maximum%20Prediction%3A%20%242.26,increase%20from%20its%20current%20value.">40% rally over the past week</a>, outpacing legacy meme coins like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>). 
What Happened: Trader RookieXBT <a href="https://x.com/RookieXBT/status/1932821896334094770">suggested</a> that Fartcoin "looks ready here," especially as markets gear up for what could be the biggest risk-on melt-up of the cycle. 
He pointed to Fartcoin&#8217;s positioning in a highly speculative environment as a key factor for potential explosive gains.
Another trader, MaxBecauseBTC, noted that a breakout in Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) above $3,000 could provide the final push for meme coins, including Fartcoin, to enter a fresh bullish phase.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fartcoin looks ready here. Memes as a basket are just waiting for <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> to push to 3k &amp; the next leg on for risk across the board should kick in. <a href="https://t.co/t6ZR9o5BRQ">pic.twitter.com/t6ZR9o5BRQ</a>
&mdash; Max (@MaxBecauseBTC) <a href="https://twitter.com/MaxBecauseBTC/status/1932834787149955308?ref_src=twsrc%5Etfw">June 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Technical analyst CRG <a href="https://x.com/MacroCRG/status/1932814170912924007">added</a> that Fartcoin's monthly chart reflects a strong upward structure, with momentum building toward a potential breakout to new all-time highs.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45858762/fartcoin-floats-past-dogecoin-shiba-inu-with-14-gain-is-it-headed-for-2">Fartcoin Floats Past Dogecoin, Shiba Inu With 14% Gain: Is It Headed For $2?</a>
Why It Matters: On-chain activity is also heating up. Onchain Lens <a href="https://x.com/OnchainLens/status/1932846334077485474">highlighted</a> a new wallet that withdrew 14,916 Solana, worth $2.48 million, from Binance for purchasing 1.68 million FARTCOIN at $1.14.
Coinbase <a href="https://x.com/CoinbaseAssets/status/1932838179486200111">confirmed</a> it will list Fartcoin on the Solana network starting June 12, subject to liquidity conditions. Trading will be available in supported regions via Coinbase and Coinbase Exchange.
Coinglass data revealed $6.7 million in total liquidations over the last 24 hours, with shorts accounting for $5.57 million, suggesting traders betting against Fartcoin were caught off guard by its rapid rise.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45821400/fartcoin-jumps-4-while-dogecoin-shiba-inu-fall-outperformance-is-undeniable-says-trader">Fartcoin Jumps 4% While Dogecoin, Shiba Inu Fall — &#8216;Outperformance Is Undeniable,&#8217; Says Trader</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$ETH

$SHIB

Fartcoin Surges 40% In A Week On Coinbase Listing, Outshines Dogecoin, Shiba Inu

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies OXY shares are trading higher after the company announced that its FDA-cleared ART100 system adoption has begun to impact commercialization interest and efforts.

TNMG

TNL Mediagene shares are trading higher after the company filed for the resale of up to 8 million ordinary shares by 3I.

JILL

J. Jill shares are trading lower after the company reported mixed Q1 financial results and withdrew its FY25 guidance due to economic headwinds and leadership change.

Papa John's International Shares Halted On Circuit Breaker To The Upside, Stock Now Up 5.6%

Piper Sandler analyst Brent Bracelin maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Neutral and maintains $130 price target.

ORCL

Piper Sandler Maintains Neutral on Oracle, Maintains $130 Price Target

<a href="https://www.semafor.com/article/06/11/2025/papa-johns-pzza-apollo-take-private">https://www.semafor.com/article/06/11/2025/papa-johns-pzza-apollo-take-private</a>

'Apollo, Irth Capital look to take Papa Johns private'- Semafor

<a href="https://techcrunch.com/2025/06/11/snapchat-rolls-out-a-new-8-99-lens-subscription-tier/#:~:text=Snapchat%20on%20Wednesday%20announced%20the,exclusive%20Lenses%20and%20AR%20experiences" title="https://techcrunch.com/2025/06/11/snapchat-rolls-out-a-new-8-99-lens-subscription-tier/#:~:text=Snapchat%20on%20Wednesday%20announced%20the,exclusive%20Lenses%20and%20AR%20experiences">https://techcrunch.com/2025/06/11/snapchat-rolls-out-a-new-8-99-lens-subscription-tier/#:~:text=Snapchat%20on%20Wednesday%20announced%20the,exclusive%20Lenses%20and%20AR%20experiences</a>.

SNAP

'Snapchat Rolls Out A New $8.99 Lens+ Subscription Tier' - Tech Crunch

Press Releases

Howmet Aerospace to Present at Barclays 2025 Industrial Select Conference

Howmet Aerospace Reports Fourth Quarter and Full Year 2024 Results

Howmet Aerospace to Participate in the Bank of America Global Industrials Conference

Howmet Aerospace Board Approves Common and Preferred Stock Dividends

Howmet Aerospace to Host Webcast and Announce First Quarter 2025 Results

NUBURU (BURU) Secures $3.4M Debt Resolution, Targets Revenue with Defense Sector Expansion

Howmet Aerospace Reports First Quarter 2025 Results

NUBURU (BURU) Revitalizes Blue Laser Business Unit with Strategic Defense Industry Focus

Howmet Aerospace to Host Virtual Webcast of Annual Meeting of Shareholders

Howmet Aerospace to Present at Bernstein's 41st Annual Strategic Decisions Conference (SDC)

Comments

Howmet Aerospace

Notizie

Ultime notizie per Howmet Aerospace (NYSE:HWM) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO